drugset / Trial / NCT01513850
A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to Evaluate the efficacy and safety of Hepabulin IV (HBIG, a study drug) after liver transplantation.
Timeline
- Start
- 2010-10
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hepatitis B immune globulin | Protein / enzyme biologic | — | Intravenous |